Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The effect of ticagrelor on the adenosine system.

Trial Profile

The effect of ticagrelor on the adenosine system.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Jan 2014

At a glance

  • Drugs Ticagrelor (Primary)
  • Indications Acute coronary syndromes; Coronary artery disease; Embolism and thrombosis; Peripheral arterial disorders
  • Focus Pharmacodynamics
  • Acronyms Ticagrelor-adenosine
  • Most Recent Events

    • 09 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 01 Dec 2013 Planned End Date changed from 3 Oct 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top